Predicting non-sentinel lymph node metastasis in Australian breast cancer patients: are the nomograms still useful in the post-Z0011 era?

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Axillary lymph node dissection (ALND) can be avoided in breast cancer patients with low-volume disease in the sentinel lymph nodes (SLNs) according to Z0011 trial. We believe that nomograms developed for predicting non-sentinel lymph node (NSLN) metastases can guide the axillary treatment in patients who do not fully match the criteria of Z0011 study. We identified risk factors and evaluated the performance of three nomograms to predict NSLN status in patients with positive SLNs.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): ANZ J Surg

Title: ANZ journal of surgery

Publisher: Wiley

ISSN (Electronic): 1445-2197

ISSN (Print): 1445-1433

Publication date (Electronic): June 2019

Volume: 89

Issue: 6

Affiliations

[1 ] Department of Breast Surgery, Royal Prince Alfred Hospital and Chris O'Brien Lifehouse, Sydney, New South Wales, Australia.

[2 ] General Surgery Unit, Calvary Hospital, Canberra, Australian Capital Territory, Australia.

Article

DOI: 10.1111/ans.15173

PubMed ID: 31066184

SO-VID: b988841c-fabf-4a60-9193-4e2564c07ac3

History

Keywords: breast cancer,external validation,nomogram,non-sentinel lymph node metastasis,sentinel lymph node biopsy

Data availability:

Keywords: breast cancer, external validation, nomogram, non-sentinel lymph node metastasis, sentinel lymph node biopsy

Predicting non-sentinel lymph node metastasis in Australian breast cancer patients: are the nomograms still useful in the post-Z0011 era?

Read this article at

Abstract

Related collections

Karger: Oncology

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 250

Cited by 7